PMC:7507645 / 31839-32106
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7507645","sourcedb":"PMC","sourceid":"7507645","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7507645","text":"Conclusion\nResults from these post hoc analyses demonstrated that fremanezumab was efficacious in the preventive treatment of patients with CM regardless of the presence of MO and increased the likelihood of reversion from medication overuse to no medication overuse.","divisions":[{"label":"title","span":{"begin":0,"end":10}}],"tracks":[]}